Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12,733,410
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
4,729,017
-
Shares change
-
+29,501
-
Total reported value, excl. options
-
$122,230,018
-
Value change
-
+$965,764
-
Number of buys
-
19
-
Number of sells
-
-28
-
Price
-
$25.77
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q1 2021
58 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q1 2021.
IRADIMED CORP - Common Stock (IRMD) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,729,017 shares
of 12,733,410 outstanding shares and own 37.14% of the company stock.
Largest 10 shareholders include Nine Ten Capital Management LLC (761,619 shares), RENAISSANCE TECHNOLOGIES LLC (723,614 shares), Soleus Capital Management, L.P. (482,070 shares), BlackRock Inc. (409,710 shares), Russell Investments Group, Ltd. (330,729 shares), VANGUARD GROUP INC (301,960 shares), RK Capital Management, LLC (232,500 shares), RICE HALL JAMES & ASSOCIATES, LLC (230,325 shares), Ranger Investment Management, L.P. (216,662 shares), and Mondrian Investment Partners LTD (178,478 shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.